Foreign drug makers must overcome challenges from Korean competitors
Despite the brisk EDI (electronic data interchange) claim results for the first half of this year, foreign players like Pfizer are expected to face an uphill battle in Korea due to intensifying competition from domestic markers, industry sources said recently.
Pfizer Korea's Norvasc (a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
